NIH: Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01- Clinical Trial Optional)RFA-DK-18-017
Sponsor: NIHInternal Deadline: 01/03/2019Institutional Submission Limit: 1Sponsor Deadline: 02/21/2019Program WebsiteNIH: Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01- Clinical Trial Optional)RFA-DK-18-017
This FOA encourages applications that expand the number of genes and range of IBD-related phenotypes and physiological domains under study by means of collaborations of the IBDGC with investigators with expertise complementary to that of their own members. Proposed studies must not duplicate studies either ongoing or already completed by the IBDGC. Multi-site clinical trials will not be considered responsive to this FOA.
USC may only submit only one application in response to this program announcement. Your application submission MUST be coordinated with the Office of the Vice President for Research. Please send a two page abstract via email to Richard White (firstname.lastname@example.org) by January 3, 2019. In addition to the 2-page abstract, you should also submit a biosketch for the PI.
NIH indicates that a letter of intent is NOT REQUIRED and a completed application is due by February 21, 2019. For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-017.html